(Q73468817)

English

Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and their relation to estradiol receptor (ER) status

scientific article published on 01 June 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9204213%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and their relation to estradiol receptor (ER) status (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9204213%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9204213%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

D Torregrosa

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9204213%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P Bolufer

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9204213%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J A López

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9204213%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

E Barragán

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9204213%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A Ruiz

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9204213%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

V Guillem

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9204213%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

B Munárriz

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9204213%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J García Conde

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9204213%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 June 1997

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9204213%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Clinica Chimica Acta

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9204213%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

262

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9204213%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

99-119

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9204213%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1-2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9204213%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Prognostic factors for recurrence and survival in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Autophosphorylation sites on the epidermal growth factor receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

The neu oncogene encodes an epidermal growth factor receptor-related protein

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

HER-2/neu oncogene protein and prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Genetic markers as prognostic indicators in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

A Mr = 190,000 glycoprotein phosphorylated on tyrosine residues in epidermal growth factor stimulated KB cells is the product of the c-erbB-2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Epidermal growth factor receptor in human breast cancer: correlation with cytosolic and nuclear ER receptors and with biological and histological tumor characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Estradiol receptors in combination with neu or myc oncogene amplifications might define new subtypes of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Epidermal growth factor receptor and prognosis in human breast cancer: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: results of a 10 year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical study and an immunocytochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Prognostic value of a solubilized fraction of EGF receptors in primary breast cancer using an immunoenzymatic assay--a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Prognostic value of epidermal growth factor receptor in node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906542-X

7 January 2021

Identifiers

10.1016/S0009-8981(97)06542-X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9204213%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9204213%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73468817&oldid=2055101381"